Open AccessEXTH-07. MUTANT ISOCITRATE DEHYDROGENASE 1 (IDH1) INHIBITOR SYC-435 SYNERGISTICALLY PROLONGS ANIMAL SURVIVAL WITH STANDARD THERAPIES IN PATIENT-DERIVED IDH1 MUTANT GLIOMA XENOGRAFT MOUSE MODELS
Author(s) -
Mari Kogiso,
Lin Qi,
Huiyuan Zhang,
Frank Braun,
Yuchen Du,
Yulun Huang,
Holly Lindsay,
Sibo Zhao,
Sarah G. Injac,
Zhen Liu,
Patricia Baxter,
Jack Su,
László Perlaky,
Donald W. Parsons,
Murali Chintagumpala,
Adekunle M. Adesina,
Jialiang Wang,
Yongcheng Song,
Xiaonan Li
Publication year - 2017
Publication title -
neuro-oncology
Language(s) - English
Resource type - Journals
eISSN - 1523-5866
pISSN - 1522-8517
DOI - 10.1093/neuonc/nox168.303
Subject(s) - isocitrate dehydrogenase , idh1 , mutant , glioma , cancer research , biology , chemistry , enzyme , biochemistry , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom